ASSET | YEAR | % RETURN |
---|---|---|
Anavex Life Sciences (AVXL) | 2015 | 632.89% |
Galapagos NV ADR (GLPG) | 2015 | 231.72% |
eXp World (EXPI) | 2015 | 184.62% |
Heron Therapeuti (HRTX) | 2015 | 162.28% |
LeMaitre Vascular (LMAT) | 2015 | 137.19% |
Smith & Wesson Brands (SWBI) | 2015 | 130.16% |
Collegium Pharmaceutical (COLL) | 2015 | 129.17% |
Iradimed (IRMD) | 2015 | 118.99% |
Frp Holdings Ord (FRPH) | 2015 | 106.46% |
MaxLinear (MXL) | 2015 | 97.19% |
American Woodmark (AMWD) | 2015 | 96.66% |
Amark Preci (AMRK) | 2015 | 95.49% |
NeoGenomics (NEO) | 2015 | 91.95% |
Cantaloupe (CTLP) | 2015 | 90.12% |
Volaris (VLRS) | 2015 | 89.2% |
Hackett (HCKT) | 2015 | 86.32% |
Rocket Pharmaceuticals (RCKT) | 2015 | 85.74% |
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN) | 2015 | 85.11% |
Lendingtree (TREE) | 2015 | 84.08% |
Genie Energy (GNE) | 2015 | 83.63% |
LSI Industries (LYTS) | 2015 | 81.59% |
Sturm Ruger (RGR) | 2015 | 74.29% |
Integra LifeSciences (IART) | 2015 | 74.22% |
Nordic American Tankers (NAT) | 2015 | 70.54% |
Zevra Therapeutics (ZVRA) | 2015 | 69.02% |